These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36076516)

  • 1. Artesunate as a glycoprotein VI antagonist for preventing platelet activation and thrombus formation.
    Lu WJ; Tsai CH; Chen RJ; Huang LT; Chen TY; Chen LC; Wang HH; Peng HY; Sun YY; Lin KH
    Biomed Pharmacother; 2022 Sep; 153():113531. PubMed ID: 36076516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways.
    Lien LM; Lin KH; Huang LT; Tseng MF; Chiu HC; Chen RJ; Lu WJ
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling.
    Irfan M; Jeong D; Saba E; Kwon HW; Shin JH; Jeon BR; Kim S; Kim SD; Lee DH; Nah SY; Rhee MH
    Platelets; 2019; 30(5):589-598. PubMed ID: 29870296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI.
    Shih TL; Lin KH; Chen RJ; Chen TY; Kao WT; Liu JW; Wang HH; Peng HY; Sun YY; Lu WJ
    J Cell Mol Med; 2021 Oct; 25(19):9434-9446. PubMed ID: 34448532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel exerts antiplatelet and antithrombotic activities: Additional benefit from use of paclitaxel-coated balloons and -eluting stents in coronary revascularization and prevention of in-stent restenosis.
    Lin KH; Li JY; Chen RJ; Chen TY; Hsu SH; Wang HH; Peng HY; Sun YY; Lu WJ
    Thromb Res; 2023 May; 225():63-72. PubMed ID: 37030187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-Trans Retinoic Acid Impairs Platelet Function and Thrombus Formation and Inhibits Protein Kinase CßI/δ Phosphorylation.
    Luo Q; Wei G; Wang X; Xu X; Ju W; Li Z; Gardiner EE; Andrews RK; Zeng L; Xu K; Qiao J
    Thromb Haemost; 2019 Oct; 119(10):1655-1664. PubMed ID: 31370073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI.
    Pan G; Chang L; Zhang J; Liu Y; Hu L; Zhang S; Zhang J; Qiao J; Jakopin Ž; Hu H; Dong J; Ding Z
    Biochem Pharmacol; 2021 Jan; 183():114315. PubMed ID: 33152345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet glycoprotein VI cluster size is related to thrombus formation and phosphatidylserine exposure in collagen-adherent platelets under arterial shear.
    Jooss NJ; Smith CW; Pike JA; Farndale RW; Henskens YMC; Watson SP; Heemskerk JWM; Poulter NS
    J Thromb Haemost; 2023 Aug; 21(8):2260-2267. PubMed ID: 37150294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Platelet Glycoprotein VI and Tyrosine Kinase Syk in Thrombus Formation on Collagen-Like Surfaces.
    Jooss NJ; De Simone I; Provenzale I; Fernández DI; Brouns SLN; Farndale RW; Henskens YMC; Kuijpers MJE; Ten Cate H; van der Meijden PEJ; Cavill R; Heemskerk JWM
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.
    Endale M; Lee WM; Kamruzzaman SM; Kim SD; Park JY; Park MH; Park TY; Park HJ; Cho JY; Rhee MH
    Br J Pharmacol; 2012 Sep; 167(1):109-27. PubMed ID: 22471932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redundancy and interaction of thrombin- and collagen-mediated platelet activation in tail bleeding and carotid thrombosis in mice.
    Bynagari-Settipalli YS; Cornelissen I; Palmer D; Duong D; Concengco C; Ware J; Coughlin SR
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2563-9. PubMed ID: 25278288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
    Ahmed MU; Kaneva V; Loyau S; Nechipurenko D; Receveur N; Le Bris M; Janus-Bell E; Didelot M; Rauch A; Susen S; Chakfé N; Lanza F; Gardiner EE; Andrews RK; Panteleev M; Gachet C; Jandrot-Perrus M; Mangin PH
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2127-2142. PubMed ID: 32698684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression.
    Ohlmann P; Hechler B; Ravanat C; Loyau S; Herrenschmidt N; Wanert F; Jandrot-Perrus M; Gachet C
    J Thromb Haemost; 2008 Jun; 6(6):1003-11. PubMed ID: 18419749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
    Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
    FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein VI - novel target in antiplatelet medication.
    Borst O; Gawaz M
    Pharmacol Ther; 2021 Jan; 217():107630. PubMed ID: 32681846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
    Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
    Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis.
    Qiao J; Wu X; Luo Q; Wei G; Xu M; Wu Y; Liu Y; Li X; Zi J; Ju W; Fu L; Chen C; Wu Q; Zhu S; Qi K; Li D; Li Z; Andrews RK; Zeng L; Gardiner EE; Xu K
    Haematologica; 2018 Sep; 103(9):1568-1576. PubMed ID: 29794149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,8-Cineole Affects Agonists-Induced Platelet Activation, Thrombus Formation and Haemostasis.
    Alatawi KA; Ravishankar D; Patra PH; Bye AP; Stainer AR; Patel K; Widera D; Vaiyapuri S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Thrombotic Effects of Artesunate through Regulation of cAMP and PI3K/MAPK Pathway on Human Platelets.
    Yoon SS; Kwon HW; Shin JH; Rhee MH; Park CE; Lee DH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.